Gefitinib and oral intake reduced Patient Reports February 12, 2012
Gefitinib Side Effects Report #4920025-7
Gefitinib side effect was reported by a Physician from UNITED KINGDOM on July 20, 2005. Male patient, weighting 133.2 lb, was diagnosed with non-small cell lung cancer, analgesic effect, depression
, insomnia, pain
, muscle spasms and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, disease progression, intestinal obstruction, liver function test abnormal, oral intake reduced, pain
, renal failure, somnolence. Gefitinib dosage: unknown. During the same period patient was treated with GABAPENTIN, ACETAMINOPHEN, CARBAMAZEPINE, VENLAFAXINE, CLONAZEPAM, HALOPERIDOL, BUSCOPAN. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4941031-2
Gefitinib side effect was reported by a Physician from UNITED KINGDOM on July 20, 2005. Male patient, weighting 133.2 lb, was diagnosed with non-small cell lung cancer, analgesic effect, depression
, insomnia, pain
, muscle spasms and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, intestinal obstruction, liver function test abnormal, malignant neoplasm progression, non-small cell lung cancer, oral intake reduced, overgrowth bacterial, pain
. Gefitinib dosage: unknown. During the same period patient was treated with GABAPENTIN, ACETAMINOPHEN, CARBAMAZEPINE, VENLAFAXINE, CLONAZEPAM, HALOPERIDOL, BUSCOPAN. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #5063839-8
Gefitinib side effect was reported by a Health Professional from UNITED STATES on July 26, 2006. Female patient, weighting 213.8 lb, was diagnosed with glioblastoma multiforme and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: nausea
, oral intake reduced, vertigo. Gefitinib dosage: 750 MG PO, QD. During the same period patient was treated with RAPAMUNE, DILANTIN, LIPITOR, LOVENOX, DECADRON, ZANTAC, BACTRIM DS. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4588569-8
Gefitinib side effect was reported by a Health Professional from on Feb 14, 2005. Male patient, weighting 172.4 lb, was diagnosed with glioblastoma multiforme and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: oral intake reduced, post procedural vomiting. Gefitinib dosage: 1000MG PO DAILY. During the same period patient was treated with RAPAMUNE, PROZAC, PREVACID, DILANTIN, DECADRON. Patient was hospitalized. Patient recovered.
Gefitinib Side Effects Report #4798171-0
Gefitinib side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2005. Female patient, weighting 213.8 lb, was diagnosed with glioblastoma multiforme and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, oral intake reduced. Gefitinib dosage: 750 MG PO, QD. During the same period patient was treated with RAPAMUNE, AVALIDE, DECADRON, KEPPRA, PEPCID, LOVENOX, MAGIC MOUTHWASH, PHENERGAN. Patient was hospitalized. Patient recovered.
Gefitinib Side Effects Report #4826726-3
Gefitinib side effect was reported by a Health Professional from UNITED STATES on Nov 10, 2005. Female patient, weighting 213.8 lb, was diagnosed with glioblastoma multiforme and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: asthenia, dehydration, diarrhoea, escherichia infection, nausea
, oral intake reduced. Gefitinib dosage: 750 MG PO QD. During the same period patient was treated with RAPAMUNE, AVALIDE, DECADRON, KEPPRA, PEPCID, LOVONOX, MAGIC MOUTHWASH, PHENERGAN. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4891007-9
Gefitinib side effect was reported by a Health Professional from UNITED STATES on Jan 24, 2006. Female patient, weighting 213.8 lb, was diagnosed with glioblastoma multiforme and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: blood pressure abnormal, dehydration, nausea
, oral intake reduced. Gefitinib dosage: 750 MG, PO, QD. During the same period patient was treated with RAPAMUNE, LOVENOX, SULFAMETH, PHENYTOIN EX, NYSTATIN, ZANTAC, LIPITOR, CALCIUM. Patient was hospitalized. Patient recovered.
Gefitinib and oral intake reduced 